Medicine & pharma · Pipeline & development
Innovative Immunology Biotech Windward Bio Lists on Nasdaq
SHANGHAI, Nov. 14, 2026 /PRNewswire/ -- Windward Bio, a portfolio company of Qiming Venture Partners and a clinical-stage biotechnology company, successfully listed on Nasdaq on November 13, 2026. Windward Bio (Nasdaq: WWB) priced its IPO at $17.00 per share. Its shares closed at $28.50...
Original source
Read the source — prnewswire.com ↗We link to the original publisher. The summary above is a short guide; read the original for the full details.